HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $53,956,620 | +38.0% | 948,271 | -4.1% | 0.01% | +30.0% |
| Q3 2022 | $39,104,625 | -28.0% | 988,989 | -19.8% | 0.01% | -28.6% |
| Q2 2022 | $54,284,164 | +14.8% | 1,233,731 | +4.1% | 0.01% | +40.0% |
| Q1 2022 | $47,284,320 | +12.4% | 1,185,665 | +13.3% | 0.01% | +11.1% |
| Q4 2021 | $42,068,000 | +0.9% | 1,046,198 | +2.1% | 0.01% | 0.0% |
| Q3 2021 | $41,684,000 | +13.7% | 1,024,681 | +26.9% | 0.01% | +12.5% |
| Q2 2021 | $36,670,000 | -26.7% | 807,540 | -32.7% | 0.01% | -27.3% |
| Q1 2021 | $50,005,000 | +3.0% | 1,199,438 | +5.5% | 0.01% | 0.0% |
| Q4 2020 | $48,546,000 | +76.4% | 1,136,645 | +8.5% | 0.01% | +57.1% |
| Q3 2020 | $27,519,000 | -15.1% | 1,047,150 | -13.3% | 0.01% | -22.2% |
| Q2 2020 | $32,399,000 | +17.8% | 1,208,474 | -20.9% | 0.01% | -10.0% |
| Q1 2020 | $27,498,000 | -9.2% | 1,528,524 | -10.5% | 0.01% | +25.0% |
| Q4 2019 | $30,288,000 | +7.9% | 1,708,271 | -5.6% | 0.01% | -11.1% |
| Q3 2019 | $28,076,000 | -0.1% | 1,810,203 | +10.7% | 0.01% | 0.0% |
| Q2 2019 | $28,093,000 | +7.8% | 1,635,203 | +1.0% | 0.01% | +12.5% |
| Q1 2019 | $26,062,000 | +10.0% | 1,618,760 | 0.0% | 0.01% | -11.1% |
| Q4 2018 | $23,682,000 | -19.5% | 1,618,760 | 0.0% | 0.01% | -10.0% |
| Q3 2018 | $29,412,000 | +7.7% | 1,618,760 | 0.0% | 0.01% | +11.1% |
| Q2 2018 | $27,309,000 | +33.3% | 1,618,760 | +54.8% | 0.01% | +28.6% |
| Q1 2018 | $20,484,000 | +1.6% | 1,045,610 | +5.1% | 0.01% | 0.0% |
| Q4 2017 | $20,159,000 | +16.6% | 995,008 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $17,283,000 | +35.5% | 995,008 | 0.0% | 0.01% | +40.0% |
| Q2 2017 | $12,756,000 | -3.0% | 995,008 | -2.0% | 0.01% | 0.0% |
| Q1 2017 | $13,153,000 | +31.2% | 1,014,852 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $10,026,000 | -14.4% | 1,014,852 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $11,709,000 | +62.0% | 1,014,852 | +21.2% | 0.01% | +100.0% |
| Q2 2016 | $7,229,000 | -25.1% | 837,637 | -17.8% | 0.00% | -40.0% |
| Q1 2016 | $9,654,000 | -49.6% | 1,019,337 | -7.8% | 0.01% | -50.0% |
| Q4 2015 | $19,156,000 | +29.0% | 1,105,337 | 0.0% | 0.01% | +25.0% |
| Q3 2015 | $14,845,000 | -17.3% | 1,105,337 | +39.1% | 0.01% | -11.1% |
| Q2 2015 | $17,945,000 | +69.8% | 794,752 | +7.4% | 0.01% | +80.0% |
| Q1 2015 | $10,569,000 | +48.0% | 740,152 | 0.0% | 0.01% | +25.0% |
| Q4 2014 | $7,142,000 | -23.9% | 740,152 | -28.2% | 0.00% | -20.0% |
| Q3 2014 | $9,382,000 | -53.9% | 1,031,007 | -50.0% | 0.01% | 0.0% |
| Q2 2014 | $20,370,000 | +55.6% | 2,062,014 | +100.0% | 0.01% | -28.6% |
| Q1 2014 | $13,094,000 | -15.3% | 1,031,007 | 0.0% | 0.01% | -22.2% |
| Q4 2013 | $15,454,000 | +27.1% | 1,031,007 | -6.4% | 0.01% | +28.6% |
| Q3 2013 | $12,156,000 | +39.0% | 1,101,043 | 0.0% | 0.01% | +40.0% |
| Q2 2013 | $8,743,000 | +144.5% | 1,101,043 | +77.7% | 0.01% | +150.0% |
| Q1 2013 | $3,576,000 | -1.1% | 619,773 | +29.5% | 0.00% | 0.0% |
| Q3 2012 | $3,617,000 | -16.2% | 478,530 | 0.0% | 0.00% | -33.3% |
| Q2 2012 | $4,316,000 | – | 478,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |